As of today, Eli Lilly and Company last 12-month Revenue is $38.9 bn , EBITDA is $17.9 bn and Net Income is $7.3 bn , based on the financial report for June 30, 2024 (Q2 2024).
As of today, Eli Lilly and Company Total Assets are $71.9 bn and Total Liabilities are $58.2 bn , based on the financial report for June 30, 2024 (Q2 2024).
As of today, Eli Lilly and Company last 12-month Cash Flow from Operating Activities is $1.5 bn, Cash Flow from Investing Activities is $-2.2 bn and Cash Flow from Financing Activities is $1.6 bn, based on the financial report for June 30, 2024 (Q2 2024).
As of today, Eli Lilly and Company last 12-month Free Cash Flow is ($3.5) bn , based on the financial report for June 30, 2024 (Q2 2024).